- Home
- TLSI vs LFT Comparison
TLSI vs LFT Comparison
Compare TLSI & LFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- LFT
- Stock Information
- Founded
- TLSI 2010
- LFT 2012
- Country
- TLSI United States
- LFT United States
- Employees
- TLSI N/A
- LFT N/A
- Industry
- TLSI Medical Specialities
- LFT Real Estate Investment Trusts
- Sector
- TLSI Health Care
- LFT Real Estate
- Exchange
- TLSI Nasdaq
- LFT Nasdaq
- Market Cap
- TLSI 160.4M
- LFT 136.0M
- IPO Year
- TLSI N/A
- LFT N/A
- Fundamental
- Price
- TLSI $5.19
- LFT $2.64
- Analyst Decision
- TLSI Strong Buy
- LFT Buy
- Analyst Count
- TLSI 6
- LFT 3
- Target Price
- TLSI $11.75
- LFT $2.50
- AVG Volume (30 Days)
- TLSI 34.3K
- LFT 102.7K
- Earning Date
- TLSI 05-14-2025
- LFT 05-20-2025
- Dividend Yield
- TLSI N/A
- LFT 15.59%
- EPS Growth
- TLSI N/A
- LFT 18.59
- EPS
- TLSI N/A
- LFT 0.34
- Revenue
- TLSI $29,431,000.00
- LFT $36,218,717.00
- Revenue This Year
- TLSI $56.00
- LFT $177.59
- Revenue Next Year
- TLSI $52.17
- LFT N/A
- P/E Ratio
- TLSI N/A
- LFT $7.74
- Revenue Growth
- TLSI 58.99
- LFT 12.91
- 52 Week Low
- TLSI $3.50
- LFT $2.22
- 52 Week High
- TLSI $10.24
- LFT $2.84
- Technical
- Relative Strength Index (RSI)
- TLSI 40.35
- LFT 50.38
- Support Level
- TLSI $4.66
- LFT $2.61
- Resistance Level
- TLSI $5.35
- LFT $2.71
- Average True Range (ATR)
- TLSI 0.37
- LFT 0.06
- MACD
- TLSI -0.05
- LFT 0.01
- Stochastic Oscillator
- TLSI 43.44
- LFT 53.12
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About LFT Lument Finance Trust Inc.
Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.